385 related articles for article (PubMed ID: 23113703)
1. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Folman CC; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Transfusion; 2013 Jul; 53(7):1580-5. PubMed ID: 23113703
[TBL] [Abstract][Full Text] [Related]
2. Top-up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions.
Rath ME; Smits-Wintjens VE; Lindenburg I; Brand A; Oepkes D; Walther FJ; Lopriore E
Vox Sang; 2010 Jul; 99(1):65-70. PubMed ID: 20331535
[TBL] [Abstract][Full Text] [Related]
3. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
5. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
[TBL] [Abstract][Full Text] [Related]
6. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
[TBL] [Abstract][Full Text] [Related]
7. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
8. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
9. Neonatal morbidity after exchange transfusion for red cell alloimmune hemolytic disease.
Smits-Wintjens VE; Rath ME; van Zwet EW; Oepkes D; Brand A; Walther FJ; Lopriore E
Neonatology; 2013; 103(2):141-7. PubMed ID: 23235106
[TBL] [Abstract][Full Text] [Related]
10. Anti-D in Rh positive pregnancies.
Prasad MR; Krugh D; Rossi KQ; O'Shaughnessy RW
Am J Obstet Gynecol; 2006 Oct; 195(4):1158-62. PubMed ID: 17000249
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes.
de Winter DP; Kaminski A; Tjoa ML; Oepkes D; Lopriore E
BMC Pregnancy Childbirth; 2023 Oct; 23(1):738. PubMed ID: 37853331
[TBL] [Abstract][Full Text] [Related]
12. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn.
Trevett TN; Dorman K; Lamvu G; Moise KJ
Am J Obstet Gynecol; 2005 Feb; 192(2):478-82. PubMed ID: 15695990
[TBL] [Abstract][Full Text] [Related]
13. Rh hemolytic disease of the newborn.
Page S
Neonatal Netw; 1989 Jun; 7(6):31-41. PubMed ID: 2499756
[No Abstract] [Full Text] [Related]
14. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
[TBL] [Abstract][Full Text] [Related]
15. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
[TBL] [Abstract][Full Text] [Related]
16. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
Felc Z
East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
[No Abstract] [Full Text] [Related]
18. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
19. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
20. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
Miquel E; Cavelier B; Bonneau JC; Rouger P
Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
